Branded Generic and Proprietary Medicinal Products - Group 10
Details
- Supplier(s)
32 suppliers
- Aspire Pharma Ltd
- B BRAUN STERILOG (YORKSHIRE) LIMITED
- Baxter Healthcare Ltd
- Bayer Public Limited Company
- Bowmed Ibisqus Ltd
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Focus Pharmaceuticals Ltd
- GLAXOSMITHKLINE UK LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Grunenthal Ltd
- Janssen Cilag Ltd
- Kent Pharma (UK) Ltd
- Macure Pharma UK Ltd
- Martindale Pharma
- MERCK SHARP & DOHME (UK) LIMITED
- Mercury Pharmaceuticals Ltd
- Morningside Pharmaceuticals Ltd
- Neon Healthcare Ltd
- Norgine Pharmaceuticals Limited
- Pfizer Liimted
- ProStrakan Ltd
- Ranbaxy (UK) Ltd
- Rosemont Pharmaceuticals Ltd
- Sandoz
- Teva UK Ltd
- Thornton and Ross
- Tillomed Laboratories Ltd
- Typharm Ltd
- Viatris UK Healthcare Ltd
- Wockhardt UK Limited
- Zentiva Ltd
- Value
- GBP 9,527,104.5
- Topic
- Pharmaceutical products
- Published
- 29 September 2022
- Source
- eu:ted
Tender description
Branded Generic and Proprietary Medicinal Products - Group 10 Lot 1: Branded Generic and Proprietary Medicinal Products - Group 10 [3970432] is established under the Medicinal Products Dynamic Purchasing System [131864]. The contract is awarded on behalf of the following contract participants: (i) Belfast Health and Social Care Trust (BHSCT); (ii) South Eastern Health and Social Care Trust (SEHSCT); (iii) Northern Health and Social Care Trust (NHSCT); (iv) Southern Health and Social Care Trust (SHSCT); (v) Western Health and Social Care Trust (WHSCT); (vi) Northern Ireland Ambulance Service (NIAS); (vii) Northern Ireland Blood Transfusion Service (NIBTS); (viii) Business Services Organisation (BSO); (ix) Public Health Agency (PHA); (x) Department of Health, Northern Ireland (DoH(NI)); (xi) Health and Social Care Board (HSCB) (now Strategic Planning and Performance Group). The estimated total value of contract (excluding VAT) is GBP 9 000 000 to GBP 43 000 000. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts document and provides for potential growth of up to 50% over the course of the contract.
Timeline
- Completed: Award published29 September 2022Current notice
- Completed: Award date29 September 2022
About the buyer
HSC Business Services Organisation is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov |
6 similar open tenders
See more open tenders related to Branded Generic and Proprietary Medicinal Products - Group 10.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to HSC Business Services Organisation.
- 112£794.4m
- 18£169.3m
- 12£24.3m
- 3£4.4m
- 514£239.2m
- 381£5.3bn
- 321£279.9m
- 262£44.9m
- 244£140.9m
- 231£25.7m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
